Information Provided By: 
Fly News Breaks for July 19, 2017
REGN
Jul 19, 2017 | 06:56 EDT
BofA/Merrill analyst Ying Huang added Regeneron to the US 1 List saying he expects upside to be driven by a strong base of business, higher Dupixent sales, and a best-in-class pipeline that will drive long-term growth. Huang rates Regeneron a Buy with a $593 price target.
News For REGN From the Last 2 Days
There are no results for your query REGN
